(3.145.38.117)
Users online: 15875     
Ijournet
Email id
 

Research Journal of Pharmacy and Technology
Year : 2023, Volume : 16, Issue : 12
First page : ( 5754) Last page : ( 5759)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2023.00931

Correlation between Transforming Growth Factor-Beta Levels and Skin Disorder Levels based on Modified Rodnan’s Skin Scores in Systemic Sclerosis Patients

Novianty Zuhria1,*, Tjandrawati Anna2, Rostini Tiene2, Prihatni Delita2, Dewi Sumartini3

1Clinical Pathology Specialization Program, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia

2Department of Clinical Pathology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia

3Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia

*Corresponding Author E-mail: zuha.ria@gmail.com

Online Published on 07 February, 2024.

Abstract

Systemic sclerosis is a chronic connective tissue disease characterized by the excessive formation of fibrous tissue. The current determination of systemic sclerosis progression uses the modified Rodnan’s skin score (MRSS), which is checked manually by assessing skin stiffness based on subjective pinching. Transforming growth factor-beta (TGF-β) is a major cytokine in the formation of fibrous tissue as the potential marker of systemic sclerosis progression and the targeting therapy. This study aims to determine the correlation between TGF-β levels and modified Rodnan’s skin score in systemic sclerosis patients.This study was a cross-sectional design and carried out in September 2021 at RSUP Dr. Hasan Sadikin, Bandung. This research examined 33 samples of the biological material of systemic sclerosis patients obtained from a study entitled "Development of a Systemic Sclerosis Registry System Based on Electronic Medical Records" which were stored at -80 °C. A TGF-β test was performed at the Clinical Laboratory of Hasan Sadikin General Hospital, Bandung.The results of this study showed that the mean TGF-β level was 19.6 + 4.7 ng/mL. We found a significant moderate correlation between TGF-β and modified Rodnan’s skin score with an R-value of 0.513 and a p-value of 0.002.In conclusion, there is a statistically significant moderate positive correlation between TGF-β levels and modified Rodnan’s skin scores in patients with systemic sclerosis. Although TGF-β is the main mediator of fibrous tissue formation, there are many other mediators.

Top

Keywords

Modified Rodnan’s skin score, Systemic sclerosis, Transforming growth factor-beta.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
747,116,023 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.